Resective Epilepsy Surgery, Quality of life and Economic evaluation.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21022

Enrollment

100

Registered

2020-01-08

Start date

2019-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Included will be patients that are selected for surgery between September 2019 and September 2021 in the Maastricht UMC+ and Amsterdam UMC.

Exclusion criteria

Exclusion criteria: Excluded will be patients who do not speak Dutch or patients who are considered mentally deficient (TIQ below 70), because they are expected not to be able to fill out the questionnaires. With a disharmonic level of intelligence the verbal IQ (<70) is leading.

Design outcomes

Primary

Measure	Time frame
Primary outcome is change in disease specific quality of life (expressed in points change at the QOLIE-31 questionnaire).	—

Secondary

Measure	Time frame
Secondary outcomes are change in general quality of life (expressed in points change at the EQ-5D questionnaire), seizure frequency (ILAE-classification), use of care (iMCQ), productivity (iPCQ), the correlation between change in quality of life and seizure reduction. Also, based on these outcomes, an economic evaluation will be performed.	—

Contacts

Public ContactJulia Kellenaers

Maastricht UMC+

julia.kellenaers@mumc.nl+31615061553

Outcome results